AdvanSix Inc. (ASIX)
NYSE · Plastic Materials, Synth Resins & Nonvulcan Elastomers · Manufacturing · CIK 1673985 · fiscal year ends in Dec
Closing price $15.32 on 30 Oct 2026; 52-week range $14.30 to $26.17.
Key figures
The last twelve months reported, with the latest price and balance sheet.
- Revenue, last twelve months
- $1.6B
- Revenue growth
- 3.0%
- Net income, last twelve months
- -$17.7M
- Earnings per share
- -$0.66
- Gross margin
- 5.6%
- Net margin
- -1.1%
- Free cash flow
- -$25.8M
- Return on equity
- -2.2%
- Market value
- $413.7M
- Dividend yield
- 4.2%
- Cash
- $7.2M
- Debt
- $275.0M
- Debt to equity
- 0.35
- Shares outstanding
- 27.0M
Financial statements
Revenue, profit and cash flow by fiscal year, each year linked to its annual report.
| Fiscal year | Year end | Revenue | Operating income | Net income | EPS | Free cash flow | Filing |
|---|---|---|---|---|---|---|---|
| FY2025 | 31 Dec 2025 | $1.5B | – | $49.3M | $1.80 | $6.4M | 10-K filed 20 Feb 2026 |
| FY2024 | 31 Dec 2024 | $1.5B | – | $44.1M | $1.62 | $1.7M | 10-K filed 21 Feb 2025 |
| FY2023 | 31 Dec 2023 | $1.5B | – | $54.6M | $1.95 | $10.2M | 10-K filed 16 Feb 2024 |
| FY2022 | 31 Dec 2022 | $1.9B | – | $171.9M | $5.92 | $184.2M | 10-K filed 17 Feb 2023 |
| FY2021 | 31 Dec 2021 | $1.7B | – | $139.8M | $4.81 | $162.0M | 10-K filed 18 Feb 2022 |
By quarter
| Quarter | Quarter end | Revenue | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | 30 Jun 2026 | $421.3M | $3.2M | $0.12 |
| Q1 FY2026 | 31 Mar 2026 | $404.2M | -$15.5M | -$0.58 |
| Q4 FY2025 | 31 Dec 2025 | $359.9M | -$2.8M | -$0.10 |
| Q3 FY2025 | 30 Sep 2025 | $374.5M | -$2.6M | -$0.10 |
| Q2 FY2025 | 30 Jun 2025 | $410.0M | $31.4M | $1.15 |
| Q1 FY2025 | 31 Mar 2025 | $377.8M | $23.3M | $0.86 |
| Q4 FY2024 | 31 Dec 2024 | $329.1M | $352.0K | $0.01 |
| Q3 FY2024 | 30 Sep 2024 | $398.2M | $22.3M | $0.82 |
Revenue by segment
As the company reports it in the segment note of its annual report.
By product, FY2025
| Segment | Revenue | Share |
|---|---|---|
| Plant Nutrients | $563.7M | 37.0% |
| Chemical Intermediates | $377.5M | 24.8% |
| Nylon | $309.7M | 20.3% |
| Caprolactam | $271.4M | 17.8% |
By region, FY2025
| Segment | Revenue | Share |
|---|---|---|
| United States | $1.3B | 86.0% |
| International | $212.5M | 14.0% |
Company events
The newest 8-K filings of 84 held.
| Filed | Form | Event | Items |
|---|---|---|---|
| 17 Aug 2026 | 8-K | Material agreement, Agreement ended, New debt | 1.01, 1.02, 2.03, 9.01 |
| 7 Aug 2026 | 8-K | Results, Other events | 2.02, 8.01, 9.01 |
| 23 Jun 2026 | 8-K | Shareholder vote | 5.07, 9.01 |
| 8 May 2026 | 8-K | Results, Other events | 2.02, 8.01, 9.01 |
| 13 Apr 2026 | 8-K | Leadership change | 5.02, 9.01 |
| 20 Feb 2026 | 8-K | Results, Other events | 2.02, 8.01, 9.01 |
| 22 Dec 2025 | 8-K | Leadership change | 5.02, 9.01 |
| 7 Nov 2025 | 8-K | Results, Other events | 2.02, 8.01, 9.01 |
| 23 Oct 2025 | 8-K | Material agreement, New debt | 1.01, 2.03, 9.01 |
| 2 Sep 2025 | 8-K | Leadership change | 5.02, 9.01 |
| 1 Aug 2025 | 8-K | Results, Other events | 2.02, 8.01, 9.01 |
| 9 Jul 2025 | 8-K | Leadership change | 5.02, 9.01 |
Every filing
The newest filings with the SEC of 178 held.
| Filed | Form | Period |
|---|---|---|
| 17 Aug 2026 | 8-K | 14 Aug 2026 |
| 7 Aug 2026 | 10-Q | 30 Jun 2026 |
| 7 Aug 2026 | 8-K | 7 Aug 2026 |
| 23 Jun 2026 | 8-K | 22 Jun 2026 |
| 8 May 2026 | 10-Q | 31 Mar 2026 |
| 8 May 2026 | 8-K | 8 May 2026 |
| 29 Apr 2026 | ARS | 31 Dec 2025 |
| 29 Apr 2026 | DEFA14A | – |
| 29 Apr 2026 | DEF 14A | 22 Jun 2026 |
| 13 Apr 2026 | 8-K | 13 Apr 2026 |
| 20 Feb 2026 | 10-K | 31 Dec 2025 |
| 20 Feb 2026 | 8-K | 20 Feb 2026 |
Planned insider sales
Form 144 notices, filed when the sell order goes to the broker.
| Filed | Seller | Shares | Value | Planned sale |
|---|---|---|---|---|
| 10 Jun 2026 | Gramm Christopher, Officer | 2,000 | $42.8K | 10 Jun 2026 |
| 13 May 2026 | Gramm Christopher, Officer | 2,000 | $45.1K | 13 May 2026 |
Large holders
Schedule 13D and 13G filings by holders of more than 5% of the voting shares.
| Filed | Holder | Schedule | Stake | Shares |
|---|---|---|---|---|
| 14 Aug 2026 | American Century Investment Management, Inc. | 13G | 5.1% | 1.4M |
| 14 Jul 2026 | Dimensional Fund Advisors LP | 13G | 5.2% | 1.4M |
| 14 May 2026 | CastleKnight Master Fund LP | 13G | 6.2% | 1.7M |
| 24 Apr 2026 | BlackRock, Inc. | 13G amended | 7.1% | 1.9M |
| 26 Mar 2026 | The Vanguard Group | 13G amended | 0% | 0 |
| 11 Feb 2026 | Victory Capital Management, Inc. | 13G amended | 0.51% | 137.6K |
| 30 Jan 2026 | The Vanguard Group | 13G amended | 6.35% | 1.7M |
| 21 Jan 2026 | Dimensional Fund Advisors LP | 13G amended | 4.8% | 1.3M |
| 8 Jan 2026 | BlackRock, Inc. | 13G amended | 11.9% | 3.2M |
Short interest
Shares sold short and not yet bought back, on each FINRA settlement date.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 15 Oct 2026 | 596.8K | +3.87% | 2.58 |
| 30 Sep 2026 | 574.6K | +11.92% | 1.9 |
| 15 Sep 2026 | 513.4K | -15.5% | 2.02 |
| 31 Aug 2026 | 607.6K | -5.22% | 2.23 |
| 14 Aug 2026 | 641.0K | +6.27% | 1.82 |
| 31 Jul 2026 | 603.2K | -10.1% | 2.82 |
| 15 Jul 2026 | 671.0K | -4.64% | 2.81 |
| 30 Jun 2026 | 703.6K | +17.7% | 2.21 |
Funds that hold it
From each fund's latest Form 13F.
289 funds held it at 30 Jun 2026: 94 added and 59 trimmed in the quarter. The largest:
| Fund | Shares | Value | Change in the quarter |
|---|---|---|---|
| BlackRock, Inc. | 2,440,480 | $48.5M | +156,545 |
| CastleKnight Management LP | 1,590,318 | $31.6M | +958,537 |
| Dimensional Fund Advisors LP | 1,407,349 | $28.0M | +96,343 |
| American Century Companies Inc. | 1,363,346 | $27.1M | +236,709 |
| Aegis Financial Corp. | 1,209,629 | $24.0M | 0 |
| Vanguard Capital Management LLC | 1,151,355 | $22.9M | +27,898 |
| AllianceBernstein L.P. | 863,897 | $21.1M | -7,079 |
| AQR Capital Management LLC | 700,057 | $13.9M | +61,486 |
| Geode Capital Management, LLC | 692,516 | $13.8M | +40,268 |
| Arrowstreet Capital, Limited Partnership | 664,944 | $13.2M | -63,348 |
Peers
Companies in the same industry.
- Dow Inc. (DOW): revenue $42.6B, market value $25.1B
- DuPont de Nemours, Inc. (DD): revenue $7.0B, market value $18.9B
- Albemarle Corp. (ALB): revenue $5.9B, market value $10.7B
- Eastman Chemical Co. (EMN): revenue $9.0B, market value $7.6B
- Hexcel Corp. (HXL): revenue $2.0B, market value $5.9B
- Avient Corp. (AVNT): revenue $3.3B, market value $3.9B
- Rogers Corp. (ROG): revenue $854.9M, market value $2.4B
- PureCycle Technologies, Inc. (PCT): revenue $13.8M, market value $676.0M